Tupperware Corp (TUP) 62.32 $TUP Notable Thursday Option

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tupperware Corp (TUP) 62.32 $TUP

Notable Thursday Option Activity: TUP, SCTY, BIOS
DividendChannel.com - Thu Jun 23, 10:33AM CDT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tupperware Brands Corp , where a total volume of 5,777 contracts has been traded thus far today, a contract volume which is...
TUP: 62.32 (+0.15)

Notable Two Hundred Day Moving Average Cross - TUP
DividendChannel.com - Thu Jun 16, 10:09AM CDT
In trading on Thursday, shares of Tupperware Brands Corp crossed below their 200 day moving average of $54.54, changing hands as low as $54.03 per share. Tupperware Brands Corp shares are currently trading down about 1.9% on the day.
TUP: 62.32 (+0.15)

Tupperware Brands Corporation Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Thu Jun 16, 9:30AM CDT
Tupperware Brands Corporation (NYSE: TUP) will release its second quarter 2016 earnings results on Wednesday, July 20, 2016, prior to the opening of the market, followed by its earnings release conference call at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
TUP: 62.32 (+0.15)

Packaging & Containers Equities Under Scrutiny -- Sealed Air, Berry Plastics Group, Crown Holdings, and Tupperware Brands
PR Newswire - Mon Jun 06, 7:35AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: Sealed Air Corporation (NYSE: SEE), Berry Plastics Group Inc. (NYSE: BERY), Crown Holdings Inc. (NASDAQ: CCK), and Tupperware Brands Corporation (NYSE: TUP). Learn more about these stocks by accessing their free trade alerts at:
BERY: 41.40 (+0.63), CCK: 54.14 (+1.35), SEE: 46.61 (+0.38), TUP: 62.32 (+0.15)

Tupperware Brands Corporation Declares Quarterly Dividend
PR Newswire - Tue May 24, 9:30AM CDT
Tupperware Brands Corporation (NYSE: TUP) announced today that its board of directors declared the Company's regular quarterly dividend of 68 cents per share, payable on July 6, 2016, to shareholders of record as of June 20, 2016.
TUP: 62.32 (+0.15)

Newell (NWL) to Boost Growth with New Global Headquarters
Zacks Equity Research - Zacks Investment Research - Mon May 16, 5:21AM CDT
Newell Brands (NWL) announced plans to set up its new international headquarters at Hoboken, NJ.
NWL: 53.64 (+0.13), OLLI: 26.44 (+0.08), ENR: 50.10 (+0.55), TUP: 62.32 (+0.15)

Energizer (ENR) Q2 Earnings Top Estimates, View Raised
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:55AM CDT
Energizer Holdings, Inc. (ENR) reported strong second-quarter fiscal 2016 results wherein both adjusted earnings of 30 cents per share and revenues of $334 million came in way ahead of the Zacks Consensus Estimate of 21 cents and $315.9 million, respectively.
NWL: 53.64 (+0.13), OLLI: 26.44 (+0.08), ENR: 50.10 (+0.55), TUP: 62.32 (+0.15)

Newell Brands (NWL) Beats on Q1 Earnings, Guides for 2016
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:42AM CDT
Newell Rubbermaid Inc., known as Newell Brands Inc. (NWL) since its merger with Jarden Corp., reported first-quarter 2016 adjusted earnings of 40 cents a share, beating the Zacks Consensus Estimate of 36 cents.
NWL: 53.64 (+0.13), OLLI: 26.44 (+0.08), BUFF: 25.78 (+0.14), TUP: 62.32 (+0.15)

Will Food Cost Deflation Dampen Sysco (SYY) Q3 Earnings?
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 10:41AM CDT
Sysco Corporation (SYY) is set to report fiscal third-quarter 2016 results before the opening bell on May 2.
CHD: 100.15 (+2.53), AVP: 5.08 (unch), SYY: 51.46 (+0.13), TUP: 62.32 (+0.15)

Will Loss of Contracts Hurt Molson Coors (TAP) Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 10:33AM CDT
Molson Coors Brewing Co. (TAP) is set to report first-quarter 2016 results before the opening bell on May 3.
CHD: 100.15 (+2.53), AVP: 5.08 (unch), TAP: 100.02 (+0.37), TUP: 62.32 (+0.15)

Will Nu Skin Enterprises (NUS) Beat Q1 Earnings Estimates?
Zacks Equity Research - Zacks Investment Research - Mon Apr 25, 8:40AM CDT
Nu-Skin Enterprises, Inc. (NUS) is set to report first quarter 2016 results on Apr 28, after the market closes. Last quarter, the company posted a negative surprise of 13.89%.
CHD: 100.15 (+2.53), NUS: 53.25 (+0.20), MO: 66.79 (+0.42), TUP: 62.32 (+0.15)

Kimberly-Clark (KMB) Earnings Top; Stock Falls as Sales Lag
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 9:18AM CDT
Consumer products giant Kimberly-Clark Corporation (KMB) posted mixed results in the first quarter of 2016, wherein earnings beat the Zacks Consensus Estimate but revenues missed the same due to currency headwinds.
WDFC: 114.67 (+0.11), KMB: 129.89 (+1.00), OLLI: 26.44 (+0.08), TUP: 62.32 (+0.15)

Lexmark and MGM Growth Properties gain; Coca-Cola slips
AP - Wed Apr 20, 3:53PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq stock market:
KO: 43.49 (-0.15), DFS: 56.46 (+0.13), MGP: 26.77 (+0.57), INTC: 34.47 (+0.22), TXT: 38.76 (+0.04), TUP: 62.32 (+0.15), LXK: 35.91 (-0.12)

SmarTrend Watching for Potential Rebound in Shares of Tupperware Brands After 4.25% Loss
Comtex SmarTrend(R) - Wed Apr 20, 2:23PM CDT
Tupperware Brands (NYSE:TUP) traded in a range yesterday that spanned from a low of $56.93 to a high of $60.70. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $60.42 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TUP: 62.32 (+0.15)

Tupperware Brands Set to Possibly Rebound After Yesterday's Selloff of 4.25%
Comtex SmarTrend(R) - Wed Apr 20, 2:21PM CDT
Tupperware Brands (NYSE:TUP) traded in a range yesterday that spanned from a low of $56.93 to a high of $60.70. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $60.42 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TUP: 62.32 (+0.15)

Tupperware (TUP): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 8:33AM CDT
Are you a technical investor? If so, it may be time to consider Tupperware Brands Corporation (TUP) for your portfolio
TUP: 62.32 (+0.15)

Tupperware tops Street 1Q forecasts
Automated Insights - Wed Apr 20, 6:15AM CDT
ORLANDO, Fla. (AP) _ Tupperware Brands Corp. (TUP) on Wednesday reported first-quarter earnings of $43.4 million.
TUP: 62.32 (+0.15)

Tupperware Brands Reports First Quarter 2016 Results; EPS Above High End of Guidance
PR Newswire - Wed Apr 20, 6:00AM CDT
(NYSE: TUP) Tupperware Brands Corporation today announced first quarter 2016 operating results.
TUP: 62.32 (+0.15)

Kimberly-Clark (KMB) Q1 Earnings: Will it Beat Estimates?
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 9:08AM CDT
We expect Kimberly Clark Corporation (KMB) to beat expectations when it reports first-quarter 2016 results on Apr 22, before the market opens.
HYH: 35.92 (+1.15), KMB: 129.88 (+0.99), MO: 66.79 (+0.42), TUP: 62.32 (+0.15)

Newell (NWL) Closes Jarden Merger, Creates Newell Brands
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 12:25PM CDT
Newell (NWL) effectively concluded its previously announced merger with Jarden.
JAH: 58.97 (-0.02), NWL: 53.64 (+0.13), BUFF: 25.78 (+0.14), TUP: 62.32 (+0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading